Home > Insider Trading > Filing (0001209191-20-036491)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1044378	Biocept Inc	BIOC	Pharmaceutical Preparations (2834)	CA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024004	F David Hale	C/O Biocept, Inc. 5810 Nancy Ridge Drive #150 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-06-12	159	$0.56	3,477	No	4	S	Indirect	By LLC
Common Stock	Disposition	2020-06-12	445	$0.55	112	No	4	S	Indirect	By trust
Common Stock	Disposition	2020-06-12	556	$0.56	867	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LLC
No	4	S	Indirect	By trust
No	4	S	Direct

Footnotes

The sales reported herein were made for tax planning purposes.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 105,463 fewer shares.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 16,179 fewer shares.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 41,295 fewer shares.